Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer
{{output}}
The usage of monoclonal antibodies (mAbs) and antibody fragments, as a matter associated with the biopharmaceutical industry, is increasingly growing. Harmonious with this concept, we designed an exclusive modeled single-chain variable fragment (scFv) against ... ...
